Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer
scientific article published in December 2012
Author/s
author: Mario Spatafora, Adolfo Favaretto, Alessandro Morabito, Vittorio Gebbia, Fortunato Ciardiello, Ming-Sound Tsao, Antonio Rossi, Floriana Morgillo, Salvatore Siena, Massimo Di Maio, Cesare Gridelli
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.